These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34499866)

  • 21. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Maher TM; Corte TJ; Fischer A; Kreuter M; Lederer DJ; Molina-Molina M; Axmann J; Kirchgaessler KU; Samara K; Gilberg F; Cottin V
    Lancet Respir Med; 2020 Feb; 8(2):147-157. PubMed ID: 31578169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of Fibrosing Interstitial Lung Diseases.
    Maher TM; Wuyts W
    Adv Ther; 2019 Jul; 36(7):1518-1531. PubMed ID: 31119691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The extended utility of antifibrotic therapy in progressive fibrosing interstitial lung disease.
    Sarkar P; Avram C; Chaudhuri N
    Expert Rev Respir Med; 2020 Oct; 14(10):1001-1008. PubMed ID: 32567402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in rheumatoid arthritis-associated interstitial lung disease.
    Juge PA; Crestani B; Dieudé P
    Curr Opin Pulm Med; 2020 Sep; 26(5):477-486. PubMed ID: 32701675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interstitial lung disease in systemic sclerosis: pathophysiology, current and new advances in therapy.
    Jain S; Shahane A; Derk CT
    Inflamm Allergy Drug Targets; 2012 Aug; 11(4):266-77. PubMed ID: 22506881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).
    Nasser M; Larrieu S; Boussel L; Si-Mohamed S; Bazin F; Marque S; Massol J; Thivolet-Bejui F; Chalabreysse L; Maucort-Boulch D; Hachulla E; Jouneau S; Le Lay K; Cottin V
    Respir Res; 2021 May; 22(1):162. PubMed ID: 34030695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pulmonary fibrosis].
    Prasse A; Holle JU; Müller-Quernheim J
    Internist (Berl); 2010 Jan; 51(1):6-13. PubMed ID: 19956919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs).
    Spagnolo P; Distler O; Ryerson CJ; Tzouvelekis A; Lee JS; Bonella F; Bouros D; Hoffmann-Vold AM; Crestani B; Matteson EL
    Ann Rheum Dis; 2021 Feb; 80(2):143-150. PubMed ID: 33037004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-fibrotic effects of pirfenidone by interference with the hedgehog signalling pathway in patients with systemic sclerosis-associated interstitial lung disease.
    Xiao H; Zhang GF; Liao XP; Li XJ; Zhang J; Lin H; Chen Z; Zhang X
    Int J Rheum Dis; 2018 Feb; 21(2):477-486. PubMed ID: 29316328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Advances and Future Needs in Interstitial Lung Diseases.
    Jones MG; Richeldi L
    Semin Respir Crit Care Med; 2016 Jun; 37(3):477-84. PubMed ID: 27231869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic Approach to Adult Fibrotic Lung Diseases.
    Adegunsoye A; Strek ME
    Chest; 2016 Dec; 150(6):1371-1386. PubMed ID: 27521738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic interstitial pneumonias: translating our current understanding into novel therapies.
    King TE
    Exp Lung Res; 2005 Sep; 31 Suppl 1():41-6. PubMed ID: 16395857
    [No Abstract]   [Full Text] [Related]  

  • 33. Clubbing in patients with fibrotic interstitial lung diseases.
    van Manen MJG; Vermeer LC; Moor CC; Vrijenhoeff R; Grutters JC; Veltkamp M; Wijsenbeek MS
    Respir Med; 2017 Nov; 132():226-231. PubMed ID: 29229102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms.
    Montero P; Milara J; Roger I; Cortijo J
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial.
    Visca D; Tsipouri V; Mori L; Firouzi A; Fleming S; Farquhar M; Leung E; Maher TM; Cullinan P; Hopkinson N; Wells AU; Banya W; Whitty JA; Adamali H; Spencer LG; Sestini P; Renzoni EA
    Trials; 2017 Apr; 18(1):201. PubMed ID: 28454553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management.
    Wijsenbeek M; Kreuter M; Olson A; Fischer A; Bendstrup E; Wells CD; Denton CP; Mounir B; Zouad-Lejour L; Quaresma M; Cottin V
    Curr Med Res Opin; 2019 Nov; 35(11):2015-2024. PubMed ID: 31328965
    [No Abstract]   [Full Text] [Related]  

  • 37. Progressive fibrosing interstitial lung disease: treatable traits and therapeutic strategies.
    Wongkarnjana A; Scallan C; Kolb MRJ
    Curr Opin Pulm Med; 2020 Sep; 26(5):436-442. PubMed ID: 32657838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute Respiratory Failure in Interstitial Lung Disease Complicated by Pulmonary Hypertension.
    Vahdatpour CA; Darnell ML; Palevsky HI
    Respir Med; 2020 Jan; 161():105825. PubMed ID: 31785507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial.
    Visca D; Mori L; Tsipouri V; Fleming S; Firouzi A; Bonini M; Pavitt MJ; Alfieri V; Canu S; Bonifazi M; Boccabella C; De Lauretis A; Stock CJW; Saunders P; Montgomery A; Hogben C; Stockford A; Pittet M; Brown J; Chua F; George PM; Molyneaux PL; Margaritopoulos GA; Kokosi M; Kouranos V; Russell AM; Birring SS; Chetta A; Maher TM; Cullinan P; Hopkinson NS; Banya W; Whitty JA; Adamali H; Spencer LG; Farquhar M; Sestini P; Wells AU; Renzoni EA
    Lancet Respir Med; 2018 Oct; 6(10):759-770. PubMed ID: 30170904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapies for interstitial lung disease: past, present and future.
    Kim R; Meyer KC
    Ther Adv Respir Dis; 2008 Oct; 2(5):319-38. PubMed ID: 19124380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.